The methylation data obtained in this study were consistent with what has been reported in the literature regarding different types of high-grade gliomas since methylation of the MGMT promoter is found in 50% of glioblastomas, in 75% of astrocytomas, and in almost all oligodendrogliomas [27]. Here, MGMT is linked to central nervous system cancer.